Compendium of Cancer Genome Aberrations

Changes

HAN5:Volunteer Assignments and Opportunities (view source)

Revision as of 14:22, 25 February 2024

14,897 bytes added ,  14:22, 25 February 2024
no edit summary
Line 17: Line 17:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|[[GTS5:Hereditary_papillary_renal_carcinoma_(MET)|Hereditary papillary renal carcinoma (MET)]]
+
|CHAPTER 2 (NASAL, PARANASAL, AND SKULL BASE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Respiratory_epithelial_adenomatoid_hamartoma|Respiratory epithelial adenomatoid hamartoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 28: Line 48:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_2_(RET)|Multiple endocrine neoplasia type 2 (RET)]]
+
|[[HAN5:Seromucinous_hamartoma|Seromucinous hamartoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 39: Line 59:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Juvenile_polyposis_syndrome_(BMPR1A,_SMAD4)|Juvenile polyposis syndrome (BMPR1A, SMAD4)]]
+
|[[HAN5:Nasal_chondromesenchymal_hamartoma|Nasal chondromesenchymal hamartoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 50: Line 70:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]]
+
|[[HAN5:Sinonasal_papilloma,_inverted_type|Sinonasal papilloma, inverted type]]
 
|Disease
 
|Disease
 
|
 
|
Line 61: Line 81:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Encephalocraniocutaneous_lipomatosis_(FGFR1)|Encephalocraniocutaneous lipomatosis (FGFR1)]]
+
|[[HAN5:Sinonasal_papilloma,_oncocytic_type|Sinonasal papilloma, oncocytic type]]
 
|Disease
 
|Disease
 
|
 
|
Line 72: Line 92:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Glucagon_cell_hyperplasia_and_neoplasia_(GCGR)|Glucagon cell hyperplasia and neoplasia (GCGR)]]
+
|[[HAN5:Sinonasal_papilloma,_exophytic_type|Sinonasal papilloma, exophytic type]]
 
|Disease
 
|Disease
 
|
 
|
Line 83: Line 103:  
|
 
|
 
|-
 
|-
−
|[[GTS5:McCune-Albright_syndrome_(GNAS)|McCune-Albright syndrome (GNAS)]]
+
|[[HAN5:Keratinizing_squamous_cell_carcinoma|Keratinizing squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 94: Line 114:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Sturge-Weber_syndrome_(GNAQ)|Sturge-Weber syndrome (GNAQ)]]
+
|[[HAN5:Non-keratinizing_squamous_cell_carcinoma|Non-keratinizing squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 105: Line 125:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
+
|[[HAN5:NUT_carcinoma|NUT carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 116: Line 136:  
|
 
|
 
|-
 
|-
−
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
+
|[[HAN5:SWI/SNF_complex-deficient_sinonasal_carcinoma|SWI/SNF complex-deficient sinonasal carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 127: Line 147:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Costello_syndrome_(HRAS)|Costello syndrome (HRAS)]]
+
|[[HAN5:Sinonasal_lymphoepithelial_carcinoma|Sinonasal lymphoepithelial carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 138: Line 158:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]]
+
|[[HAN5:Sinonasal_undifferentiated_carcinoma|Sinonasal undifferentiated carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 149: Line 169:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Schimmelpenning-Feuerstein-Mims_(HRAS,_KRAS)|Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]]
+
|[[HAN5:Teratocarcinosarcoma|Teratocarcinosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 160: Line 180:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Carney_complex_(PRKAR1A,_PDE8B,_PDE11A)|Carney complex (PRKAR1A, PDE8B, PDE11A)]]
+
|[[HAN5:HPV-associated_multiphenotypic_sinonasal_carcinoma|HPV-associated multiphenotypic sinonasal carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 171: Line 191:  
|
 
|
 
|-
 
|-
−
|[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]]
+
|[[HAN5:Intestinal-type_sinonasal_adenocarcinoma|Intestinal-type sinonasal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 182: Line 202:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
+
|[[HAN5:Non-intestinal-type_sinonasal_adenocarcinoma|Non-intestinal-type sinonasal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 193: Line 213:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
+
|[[HAN5:Sinonasal_tract_angiofibroma_|Sinonasal tract angiofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 204: Line 224:  
|
 
|
 
|-
 
|-
−
|[[GTS5:AXIN2-associated_polyposis_(AXIN2)|AXIN2-associated polyposis (AXIN2)]]
+
|[[HAN5:Sinonasal_glomangiopericytoma|Sinonasal glomangiopericytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 215: Line 235:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Serrated_polyposis_(RNF43)|Serrated polyposis (RNF43)]]
+
|[[HAN5:Biphenotypic_sinonasal_sarcoma|Biphenotypic sinonasal sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 226: Line 246:  
|
 
|
 
|-
 
|-
−
|[[GTS5:WT1_related_tumour_predisposition_syndrome_(WT1)|WT1 related tumour predisposition syndrome (WT1)]]
+
|[[HAN5:Chordoma|Chordoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 237: Line 257:  
|
 
|
 
|-
 
|-
−
|[[GTS5:WAGR_syndrome_(WT1)|WAGR syndrome (WT1)]]
+
|[[HAN5:Sinonasal_ameloblastoma|Sinonasal ameloblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 248: Line 268:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_1_(MEN1)|Multiple endocrine neoplasia type 1 (MEN1)]]
+
|[[HAN5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 259: Line 279:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Peutz-Jeghers_syndrome_(STK11)|Peutz-Jeghers syndrome (STK11)]]
+
|[[HAN5:Meningioma_of_the_sinonasal_tract,_ear,_and_temporal_bone|Meningioma of the sinonasal tract, ear, and temporal bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 270: Line 290:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
+
|[[HAN5:Olfactory_neuroblastoma|Olfactory neuroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 281: Line 301:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
+
|CHAPTER 3 (NASOPHARYNGEAL  TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Hairy_polyp|Hairy polyp]]
 
|Disease
 
|Disease
 
|
 
|
Line 292: Line 332:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Naevoid_basal_cell_carcinoma_syndrome_-_Gorlin_syndrome_(PTCH1,_SUFU,_GPR161)|Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]]
+
|[[HAN5:Salivary_gland_anlage_tumour|Salivary gland anlage tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 303: Line 343:  
|
 
|
 
|-
 
|-
−
|[[GTS5:SMO-related_Curry-Jones_syndrome_(SMO)|SMO-related Curry-Jones syndrome (SMO)]]
+
|[[HAN5:Low-grade_nasopharyngeal_papillary_adenocarcinoma|Low-grade nasopharyngeal papillary adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 314: Line 354:  
|
 
|
 
|-
 
|-
−
|[[GTS5:ELP1-related_medulloblastoma_predisposition_syndrome(ELP1)|ELP1-related medulloblastoma predisposition syndrome(ELP1)]]
+
|[[HAN5:Nasopharyngeal_carcinoma|Nasopharyngeal carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 325: Line 365:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Osteochondromatosis_(EXT1,_EXT2)|Osteochondromatosis (EXT1, EXT2)]]
+
|CHAPTER 4 (HYPOPHARYNGEAL, LARYNGEAL, TRACHEA, AND PARAPHARYNGEAL TUMOURS)
−
|Disease
+
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[GTS5:Brooke-Spiegler_syndrome_(CYLD)|Brooke-Spiegler syndrome (CYLD)]]
+
|[[HAN5:Squamous_papilloma_and_papillomatosis|Squamous papilloma and papillomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 347: Line 396:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]]
+
|[[HAN5:Laryngeal_and_hypopharyngeal_epithelial_dysplasia|Laryngeal and hypopharyngeal epithelial dysplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 358: Line 407:  
|
 
|
 
|-
 
|-
−
|[[GTS5:PTEN_hamartoma_tumour_syndrome_(PTEN)|PTEN hamartoma tumour syndrome (PTEN)]]
+
|[[HAN5:Conventional_squamous_cell_carcinoma|Conventional squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 369: Line 418:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Activated_Phosphatidylinositol-3-OH_kinase_δ_Syndrome_-_APDS_(PIK3CD)|Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)]]
+
|[[HAN5:Verrucous_carcinoma_of_the_hypopharynx,_larynx,_trachea,_and_parapharyngeal_space|Verrucous carcinoma of the hypopharynx, larynx, trachea, and parapharyngeal space]]
 
|Disease
 
|Disease
 
|
 
|
Line 380: Line 429:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_5,_MAX_related_tumours_(MAX)|Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]]
+
|[[HAN5:Basaloid_squamous_cell_carcinoma|Basaloid squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 391: Line 440:  
|
 
|
 
|-
 
|-
−
|[[GTS5:MAFA-related_familial_insulinomatosis_(MAFA)|MAFA-related familial insulinomatosis (MAFA)]]
+
|[[HAN5:Papillary_squamous_cell_carcinoma|Papillary squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 402: Line 451:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Birt-Hogg-Dube_syndrome_(FLCN)|Birt-Hogg-Dube syndrome (FLCN)]]
+
|[[HAN5:Spindle_cell_squamous_carcinoma|Spindle cell squamous carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 413: Line 462:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Familial_chordoma_(TBXT)|Familial chordoma (TBXT)]]
+
|[[HAN5:Adenosquamous_carcinoma|Adenosquamous carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 424: Line 473:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Hyperparathyroidism_jaw_tumour_syndrome_(CDC73)|Hyperparathyroidism jaw tumour syndrome (CDC73)]]
+
|[[HAN5:Lymphoepithelial_carcinoma_of_the_larynx|Lymphoepithelial carcinoma of the larynx]]
 
|Disease
 
|Disease
 
|
 
|
Line 435: Line 484:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Von_Hippel-Lindau_syndrome_(VHL)|Von Hippel-Lindau syndrome (VHL)]]
+
|[[HAN5:Laryngeal_cartilaginous_tumours|Laryngeal cartilaginous tumours]]
 
|Disease
 
|Disease
 
|
 
|
Line 446: Line 495:  
|
 
|
 
|-
 
|-
−
|[[GTS5:SDH-deficient_tumour_syndrome_-_Hereditary_phaeochromocytoma-paraganglioma_syndromes_(SDHA,_SDHB,_SDHC,_SDHD,_SDHAF2)|SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]]
+
|CHAPTER 5 (SALIVARY GLAND TUMOURS)
−
|Disease
+
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[GTS5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome_(FH)|Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]]
+
|[[HAN5:Nodular_oncocytic_hyperplasia|Nodular oncocytic hyperplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 468: Line 526:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_tyrosinaemia_type_1_(FAH)|Hereditary tyrosinaemia type 1 (FAH)]]
+
|[[HAN5:Lymphoepithelial_sialadenitis|Lymphoepithelial sialadenitis]]
 
|Disease
 
|Disease
 
|
 
|
Line 479: Line 537:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Li-Fraumeni_syndrome_(TP53)|Li-Fraumeni syndrome (TP53)]]
+
|[[HAN5:Pleomorphic_adenoma|Pleomorphic adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 490: Line 548:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
+
|[[HAN5:Basal_cell_adenoma|Basal cell adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 501: Line 559:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_4_(CDKN1B)|Multiple endocrine neoplasia type 4 (CDKN1B)]]
+
|[[HAN5:Warthin_tumour|Warthin tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 512: Line 570:  
|
 
|
 
|-
 
|-
−
|[[GTS5:CDKN2A-related_tumour_predisposition_syndrome_(CDKN2A)|CDKN2A-related tumour predisposition syndrome (CDKN2A)]]
+
|[[HAN5:Oncocytoma|Oncocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 523: Line 581:  
|
 
|
 
|-
 
|-
−
|[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)|CDK4-related melanoma predisposition syndrome (CDK4)]]
+
|[[HAN5:Salivary_gland_myoepithelioma|Salivary gland myoepithelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 534: Line 592:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]]
+
|[[HAN5:Canalicular_adenoma|Canalicular adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 545: Line 603:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Lynch_Syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]]
+
|[[HAN5:Cystadenoma_of_the_salivary_glands|Cystadenoma of the salivary glands]]
 
|Disease
 
|Disease
 
|
 
|
Line 556: Line 614:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Muir-Torre_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]]
+
|[[HAN5:Ductal_papillomas|Ductal papillomas]]
 
|Disease
 
|Disease
 
|
 
|
Line 567: Line 625:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
+
|[[HAN5:Sialadenoma_papilliferum|Sialadenoma papilliferum]]
 
|Disease
 
|Disease
 
|
 
|
Line 578: Line 636:  
|
 
|
 
|-
 
|-
−
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
+
|[[HAN5:Lymphadenoma_|Lymphadenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 589: Line 647:  
|
 
|
 
|-
 
|-
−
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
+
|[[HAN5:Sebaceous_adenoma_|Sebaceous adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 600: Line 658:  
|
 
|
 
|-
 
|-
−
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
+
|[[HAN5:Intercalated_duct_adenoma_and_hyperplasia|Intercalated duct adenoma and hyperplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 611: Line 669:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Fanconi_anaemia_(FANC_genes)|Fanconi anaemia (FANC genes)]]
+
|[[HAN5:Striated_duct_adenoma|Striated duct adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 622: Line 680:  
|
 
|
 
|-
 
|-
−
|[[GTS5:MUTYH-associated_polyposis_(MUTYH)|MUTYH-associated polyposis (MUTYH)]]
+
|[[HAN5:Sclerosing_polycystic_adenoma|Sclerosing polycystic adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 633: Line 691:  
|
 
|
 
|-
 
|-
−
|[[GTS5:NTHL1-related_tumour_syndrome_(NTHL1)|NTHL1-related tumour syndrome (NTHL1)]]
+
|[[HAN5:Keratocystoma|Keratocystoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 644: Line 702:  
|
 
|
 
|-
 
|-
−
|[[GTS5:MBD4-associated_neoplasia_syndrome_(MBD4)|MBD4-associated neoplasia syndrome (MBD4)]]
+
|[[HAN5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 655: Line 713:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]]
+
|[[HAN5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 666: Line 724:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
+
|[[HAN5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 677: Line 735:  
|
 
|
 
|-
 
|-
−
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
+
|[[HAN5:Secretory_carcinoma|Secretory carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 688: Line 746:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
+
|[[HAN5:Microsecretory_adenocarcinoma|Microsecretory adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 699: Line 757:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Polymerase_proofreading-associated_polyposis_(POLD1,_POLE)|Polymerase proofreading-associated polyposis (POLD1, POLE)]]
+
|[[HAN5:Polymorphous_adenocarcinoma|Polymorphous adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 710: Line 768:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Bloom_syndrome_(BLM)|Bloom syndrome (BLM)]]
+
|[[HAN5:Hyalinizing_clear_cell_carcinoma|Hyalinizing clear cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 721: Line 779:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Werner_syndrome_(WRN)|Werner syndrome (WRN)]]
+
|[[HAN5:Basal_cell_adenocarcinoma|Basal cell adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 732: Line 790:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Rothmund-Thomson_syndrome_(ANAPC1,_RECQL4)|Rothmund-Thomson syndrome (ANAPC1, RECQL4)]]
+
|[[HAN5:Intraductal_carcinoma_|Intraductal carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 743: Line 801:  
|
 
|
 
|-
 
|-
−
|[[GTS5:DDX41-related_haematologic_tumour_predisposition_syndrome_(DDX41)|DDX41-related haematologic tumour predisposition syndrome (DDX41)]]
+
|[[HAN5:Salivary_duct_carcinoma|Salivary duct carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 754: Line 812:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Mosaic_variegated_aneuploidy_(BUB1B,_CEP57,_TRIP13,_BUB1,_BUB3)|Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]]
+
|[[HAN5:Myoepithelial_carcinoma|Myoepithelial carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 765: Line 823:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Klinefelter_syndrome|Klinefelter syndrome]]
+
|[[HAN5:Epithelial-myoepithelial_carcinoma|Epithelial-myoepithelial carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Mucinous_adenocarcinoma|Mucinous adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sclerosing_microcystic_adenocarcinoma|Sclerosing microcystic adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Carcinoma_ex_pleomorphic_adenoma|Carcinoma ex pleomorphic adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Carcinosarcoma_of_the_salivary_glands|Carcinosarcoma of the salivary glands]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sebaceous_adenocarcinoma|Sebaceous adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma|Squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sialoblastoma|Sialoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Salivary_carcinoma_NOS_and_emerging_entities|Salivary carcinoma NOS and emerging entities]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sialolipoma|Sialolipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 6 (ORAL CAVITY AND MOBILE TONGUE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Necrotizing_sialometaplasia|Necrotizing sialometaplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Multifocal_epithelial_hyperplasia|Multifocal epithelial hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_melanoacanthoma|Oral melanoacanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_papilloma|Squamous papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_potentially_malignant_disorders|Oral potentially malignant disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_epithelial_dysplasia|Oral epithelial dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Proliferative_verrucous_leukoplakia|Proliferative verrucous leukoplakia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Submucous_fibrosis|Submucous fibrosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:HPV-associated_oral_epithelial_dysplasia|HPV-associated oral epithelial dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_squamous_cell_carcinoma|Oral squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Verrucous_carcinoma_of_the_oral_cavity_and_mobile_tongue|Verrucous carcinoma of the oral cavity and mobile tongue]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Carcinoma_cuniculatum|Carcinoma cuniculatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Congenital_granular_cell_epulis|Congenital granular cell epulis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ectomesenchymal_chondromyxoid_tumour|Ectomesenchymal chondromyxoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Melanotic_neuroectodermal_tumour_of_infancy|Melanotic neuroectodermal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 7 (OROPHARYNGEAL TUMOURS (BASE OF TONGUE, TONSILS, ADNOIDS))
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Hamartomatous_polyps|Hamartomatous polyps]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma,_HPV-associated|Squamous cell carcinoma, HPV-associated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma,_HPV-independent|Squamous cell carcinoma, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 8 (ODONTOGENIC AND MAXILLOFACIAL BONE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Radicular_cyst|Radicular cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Inflammatory_collateral_cysts|Inflammatory collateral cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Surgical_ciliated_cyst|Surgical ciliated cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Nasopalatine_duct_cyst|Nasopalatine duct cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Gingival_cysts|Gingival cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Dentigerous_cyst|Dentigerous cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Orthokeratinized_odontogenic_cyst|Orthokeratinized odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lateral_periodontal_cyst_and_botryoid_odontogenic_cyst|Lateral periodontal cyst and botryoid odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Calcifying_odontogenic_cyst|Calcifying odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Glandular_odontogenic_cyst|Glandular odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_keratocyst|Odontogenic keratocyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Adenomatoid_odontogenic_tumour|Adenomatoid odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_odontogenic_tumour|Squamous odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Calcifying_epithelial_odontogenic_tumour|Calcifying epithelial odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastoma,_unicystic|Ameloblastoma, unicystic]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastoma,_extraosseous/peripheral|Ameloblastoma, extraosseous/peripheral]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastoma,_conventional|Ameloblastoma, conventional]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Adenoid_ameloblastoma|Adenoid ameloblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Metastasizing_ameloblastoma|Metastasizing ameloblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontoma|Odontoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Primordial_odontogenic_tumour|Primordial odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastic_fibroma|Ameloblastic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Dentinogenic_ghost_cell_tumour|Dentinogenic ghost cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_fibroma|Odontogenic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cementoblastoma|Cementoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cemento-ossifying_fibroma|Cemento-ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_myxoma|Odontogenic myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sclerosing_odontogenic_carcinoma|Sclerosing odontogenic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastic_carcinoma|Ameloblastic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Clear_cell_odontogenic_carcinoma|Clear cell odontogenic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ghost_cell_odontogenic_carcinoma|Ghost cell odontogenic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Primary_intraosseous_carcinoma_NOS|Primary intraosseous carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_carcinosarcoma|Odontogenic carcinosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_sarcomas|Odontogenic sarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Central_giant_cell_granuloma|Central giant cell granuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Peripheral_giant_cell_granuloma|Peripheral giant cell granuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cherubism|Cherubism]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Simple_bone_cyst|Simple bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cemento-osseous_dysplasia|Cemento-osseous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Segmental_odontomaxillary_dysplasia|Segmental odontomaxillary dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Juvenile_trabecular_ossifying_fibroma|Juvenile trabecular ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Psammomatoid_ossifying_fibroma|Psammomatoid ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Familial_gigantiform_cementoma|Familial gigantiform cementoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteoma|Osteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteochondroma|Osteochondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteoblastoma|Osteoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chondroblastoma|Chondroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteosarcoma_of_the_jaw|Osteosarcoma of the jaw]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:The_chondrosarcoma_family_of_tumours|The chondrosarcoma family of tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Rhabdomyosarcoma_with_TFCP2_rearrangement_|Rhabdomyosarcoma with TFCP2 rearrangement]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 9 (EAR TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Chondrodermatitis_nodularis_chronica_helicis|Chondrodermatitis nodularis chronica helicis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cystic_chondromalacia|Cystic chondromalacia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Exostosis_(osteoma)_of_the_ear|Exostosis (osteoma) of the ear]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ceruminous_adenoma|Ceruminous adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ceruminous_adenocarcinoma|Ceruminous adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma_of_the_external_auditory_canal|Squamous cell carcinoma of the external auditory canal]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Otosclerosis|Otosclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cholesteatoma|Cholesteatoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_papilloma|Middle ear papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Vestibular_schwannoma|Vestibular schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_neuroendocrine_tumour|Middle ear neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Endolymphatic_sac_tumour|Endolymphatic sac tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_squamous_cell_carcinoma|Middle ear squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_adenocarcinoma|Middle ear adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 10 (SOFT TISSUE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Lipomas|Lipomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Liposarcomas|Liposarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Nodular_fasciitis|Nodular fasciitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Haemangioma|Haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lymphangioma|Lymphangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Kaposi_sarcoma|Kaposi sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Myofibroma|Myofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Smooth_muscle_tumour_of_uncertain_malignant_potential|Smooth muscle tumour of uncertain malignant potential]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Rhabdomyoma|Rhabdomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chondroma|Chondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Neuromas_|Neuromas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Myxoma_|Myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Extraskeletal_myxoid_chondrosarcoma|Extraskeletal myxoid chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:GLI1-altered_soft_tissue_tumour_|GLI1-altered soft tissue tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 11 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Reactive_lymphoid_hyperplasia|Reactive lymphoid hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:EBV-positive_mucocutaneous_ulcer|EBV-positive mucocutaneous ulcer]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:IgG4-related_disease|IgG4-related disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Extramedullary_myeloid_sarcoma|Extramedullary myeloid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Mantle_cell_lymphoma|Mantle cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Follicular_lymphoma|Follicular lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Paediatric-type_follicular_lymphoma|Paediatric-type follicular lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Large_B-cell_lymphoma_with_IRF4_rearrangement|Large B-cell lymphoma with IRF4 rearrangement]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Burkitt_lymphoma|Burkitt lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Plasmacytoma|Plasmacytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:T-lymphoblastic_leukaemia/lymphoma|T-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Primary_mucosal_CD30-positive_T-cell_lymphoproliferative_disorder|Primary mucosal CD30-positive T-cell lymphoproliferative disorder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Extranodal_NK/T-cell_lymphoma|Extranodal NK/T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Hodgkin_lymphoma|Hodgkin lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 12 (MELANOCYTIC TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Mucosal_melanoma|Mucosal melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 13 (TUMOURS AND TUMOUR-IIKE LESIONS OF THE NECK AND LYMPH NODES)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Ranula|Ranula]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lymphoepithelial_cyst|Lymphoepithelial cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Branchial_cleft_cyst|Branchial cleft cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Dermoid_and_teratoid_cysts|Dermoid and teratoid cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Branchioma|Branchioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Heterotopia-associated_carcinoma|Heterotopia-associated carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_carcinoma_of_unknown_primary_site|Squamous carcinoma of unknown primary site]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 14 (GERM CELL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Germ_cell_tumours_of_the_head_and_neck|Germ cell tumours of the head and neck]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 15 (METASTASIS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Metastases_to_the_head_and_neck_region|Metastases to the head and neck region]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 16 (NEUROENDOCRINE NEOPLASMS AND PARAGANGLIOMA)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Neuroendocrine_tumour|Neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ectopic_or_invasive_PitNET_/_pituitary_adenoma|Ectopic or invasive PitNET / pituitary adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Head_and_neck_paraganglioma|Head and neck paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 17 (GENETIC TUMOUR SYNDROMES INVOLVING THE HEAD AND NECK)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
 
|Disease
 
|Disease
 
|
 
|
Line 776: Line 2,944:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Turner_syndrome|Turner syndrome]]
+
|[[HAN5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
 
|
 
|
Line 787: Line 2,955:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Down_syndrome|Down syndrome]]
+
|[[HAN5:Familial_adenomatous_polyposis_and_Gardner_syndrome|Familial adenomatous polyposis and Gardner syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 798: Line 2,966:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]
+
|[[HAN5:Brooke-Spiegler_syndrome|Brooke-Spiegler syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 809: Line 2,977:  
|
 
|
 
|-
 
|-
−
|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]
+
|[[HAN5:Cowden_syndrome|Cowden syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 820: Line 2,988:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Beckwith-Wiedemann_spectrum_(IGF2;_CDKN1C)|Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]]
+
|[[HAN5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 
|Disease
 
|Disease
 
|
 
|
Line 831: Line 2,999:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Enchondromatosis_(IDH1,_IDH2)|Enchondromatosis (IDH1, IDH2)]]
+
|[[HAN5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
 
|Disease
 
|Disease
 
|
 
|
Line 842: Line 3,010:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Rhabdoid_tumour_predisposition_syndrome_(SMARCB1,_SMARCA4)|Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]]
+
|[[HAN5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 853: Line 3,021:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Schwannomatosis_(SMARCB1,_LZTR1)|Schwannomatosis (SMARCB1, LZTR1)]]
+
|[[HAN5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 864: Line 3,032:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Clear_cell_meningioma_predisposition_syndrome_(SMARCE1)|Clear cell meningioma predisposition syndrome (SMARCE1)]]
+
|[[HAN5:Fanconi_anaemia|Fanconi anaemia]]
 
|Disease
 
|Disease
 
|
 
|
Line 875: Line 3,043:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Weaver_syndrome_(EZH2)|Weaver syndrome (EZH2)]]
+
|[[HAN5:Dyskeratosis_congenita|Dyskeratosis congenita]]
 
|Disease
 
|Disease
 
|
 
|
Line 886: Line 3,054:  
|
 
|
 
|-
 
|-
−
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
+
|[[HAN5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 897: Line 3,065:  
|
 
|
 
|-
 
|-
−
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
+
|[[HAN5:Bloom_syndrome|Bloom syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 908: Line 3,076:  
|
 
|
 
|-
 
|-
−
|[[GTS5:Goldenhar_syndrome_(MYT1,_SF3B2)|Goldenhar syndrome (MYT1, SF3B2)]]
+
|[[HAN5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 919: Line 3,087:  
|
 
|
 
|-
 
|-
−
|[[GTS5:BAP1-related_tumour_predisposition_syndrome_(BAP1)|BAP1-related tumour predisposition syndrome (BAP1)]]
+
|[[HAN5:Tuberous_sclerosis|Tuberous sclerosis]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/14252...14259"